Patents by Inventor Bart Hermans

Bart Hermans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MONITORING DEVICE BEING ATTACHABLE TO AN ABSORBENT ARTICLE AND COMMUNICATION METHOD THEREFOR
    Publication number: 20230263672
    Abstract: A communication method for communication of a monitoring device being attachable to an absorbent article of a wearer with a back-end unit is provided. The communication method comprises the steps of checking proper attachment of the monitoring device to the absorbent article and/or measuring status information of the absorbent article and/or of the wearer after every first time interval in order to acquire corresponding measurement data for each respective time interval. It also comprises transmitting a trigger message comprising at least the latest measurement data from the monitoring device to the back-end unit, if the latest measurement data is different from the corresponding previous measurement data of the respective previous time interval or a second time interval has been elapsed.
    Type: Application
    Filed: July 7, 2021
    Publication date: August 24, 2023
    Inventors: Lisa HEIRMAN, Jens HELLMOLD, Bart HERMANS, Karel DE COSTER, Bert MARRES
  • Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof
    Patent number: 11673943
    Abstract: The invention provides an antibody or antigen binding fragments thereof that binds to 3pE A? and methods of making and using the antibody or antigen binding fragment thereof, including use for formulations, administration and kits. The antibody and antigen binding fragments thereof and methods disclosed are useful for diagnosis, prognosis and treatment of Alzheimer's disease or other ?-amyloid-related diseases.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: June 13, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marc Mercken, Bianca Van Broeck, Marc Vandermeeren, Bart Hermans, Astrid Bottelbergs
  • Antibodies to Pyroglutamate Amyloid-β and Uses Thereof
    Publication number: 20210147528
    Abstract: The invention provides an antibody or antigen binding fragments thereof that binds to 3pE A? and methods of making and using the antibody or antigen binding fragment thereof, including use for formulations, administration and kits. The antibody and antigen binding fragments thereof and methods disclosed are useful for diagnosis, prognosis and treatment of Alzheimer's disease or other ?-amyloid-related diseases.
    Type: Application
    Filed: November 25, 2020
    Publication date: May 20, 2021
    Applicant: Janssen Pharmaceutica NV
    Inventors: Marc Mercken, Bianca Van Broeck, Marc Vandermeeren, Bart Hermans, Astrid Bottelbergs
  • Methods of detecting pyroglutamate amyloid beta protein (3pE A?) using anti-3pE A? antibodies
    Patent number: 10851156
    Abstract: The invention provides an antibody or antigen binding fragments thereof that binds to 3pE A? and methods of making and using the antibody or antigen binding fragment thereof, including use for formulations, administration and kits. The antibody and antigen binding fragments thereof and methods disclosed are useful for diagnosis, prognosis and treatment of Alzheimer's disease or other ?-amyloid-related diseases.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: December 1, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marc Mercken, Bianca Van Broeck, Marc Vandermeeren, Bart Hermans, Astrid Bottelbergs
  • Antibodies to Pyroglutamate Amyloid-B and Uses Thereof
    Publication number: 20200165328
    Abstract: The invention provides an antibody or antigen binding fragments thereof that binds to 3pE A? and methods of making and using the antibody or antigen binding fragment thereof, including use for formulations, administration and kits. The antibody and antigen binding fragments thereof and methods disclosed are useful for diagnosis, prognosis and treatment of Alzheimer's disease or other ?-amyloid-related diseases.
    Type: Application
    Filed: November 19, 2019
    Publication date: May 28, 2020
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Marc Mercken, Bianca Van Broeck, Marc Vandermeeren, Bart Hermans, Astrid Bottelbergs
  • Antibodies to pyroglutamate amyloid-? and uses thereof
    Patent number: 10519223
    Abstract: The invention provides an antibody or antigen binding fragments thereof that binds to 3pE A? and methods of making and using the antibody or antigen binding fragment thereof, including use for formulations, administration and kits. The antibody and antigen binding fragments thereof and methods disclosed are useful for diagnosis, prognosis and treatment of Alzheimer's disease or other ?-amyloid-related diseases.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: December 31, 2019
    Assignee: Jannsen Pharmaceutica NV
    Inventors: Marc Mercken, Bianca Van Broeck, Marc Vandermeeren, Bart Hermans, Astrid Bottelbergs
  • Antibodies to Pyroglutamate Amyloid-B and Uses Thereof
    Publication number: 20180142011
    Abstract: The invention provides an antibody or antigen binding fragments thereof that binds to 3pE A? and methods of making and using the antibody or antigen binding fragment thereof, including use for formulations, administration and kits. The antibody and antigen binding fragments thereof and methods disclosed are useful for diagnosis, prognosis and treatment of Alzheimer's disease or other ?-amyloid-related diseases.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 24, 2018
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Marc Mercken, Bianca Van Broeck, Marc Vandermeeren, Bart Hermans, Astrid Bottelbergs